“This is a global trend that is expected to increase in the coming years. In Europe alone, one million IVF treatments are carried out each year; in Sweden, the corresponding number is 25,000,” says Yvonne Lundberg Giwercman, professor at Lund University who led the research. She has been researching fertility in both men and women for many years.

IVF treatment involves stimulating the woman’s ovaries to mature many eggs, which are then retrieved and fertilised with sperm in the laboratory before being returned to the uterus. There are two different types of hormone treatments to choose from for egg maturation: biological or synthetic. But the powerful hormone therapy also carries the risk of serious side effects, sometimes requiring women to go into intensive care — and many attempts at IVF fail. In Sweden, the government subsidises up to three IVF cycles.

“There is an over-reliance on IVF treatments. Around 75 per cent of all attempts fail and up to 20 per cent of women experience side effects, some serious enough to require emergency treatment. The choice of hormone therapy is a contributing factor, and a major challenge is that healthcare today to some extent has to guess which treatment is best for the woman,” says Ida Hjelmér, PhD and laboratory researcher at Lund University and first author of the study.

To find out who responds best to which hormone treatment, the researchers turned to genetics. A total of 1,466 women undergoing IVF treatment at the Reproductive Medicine Centre at Skåne University Hospital in Malmö, Sweden were included in the study. Women with endometriosis or polycystic ovary syndrome (PCOS) were excluded. Of the 1,466 women, 475 were randomised to two different hormone treatments while the rest were controls. One candidate gene that is involved in fertilisation by mediating the action of follicle-stimulating hormone (FSH), which is known to play an important role in egg maturation, was of particular interest and mapped by gene sequencing.

The study identified that women with a particular variant of the FSH receptor (FSHR) gene that mediates the action of the hormone responded best to the biological hormone treatment, while others benefited from receiving the synthetic type of hormone. By knowing the woman’s genetic profile in advance, we can increase the number of successful pregnancies, says Yvonne Lundberg Giwercman.

“We see an increase in the number of pregnancies and a relative number of 38% more babies born among women who received hormone therapy that matched their gene variation compared with those who did not. This means that for every 1,000 women undergoing IVF treatment, the equivalent of four more school classes are born: 110 more babies,” says Yvonne Lundberg Giwercman.

But mapping genes is costly and takes time. That is why the researchers have now developed a simple oral swab test, which within an hour shows which hormone therapy is most suitable. The result can be seen with the naked eye as a pink or yellow coulour.

The researchers have applied for a patent for the test, set up the company Dx4Life AB and are supported in the process by LU Innovation, LU Ventures and the SmiLe Incubator with a view to commercialising the product.

“Our hope is that this will reduce the risk of suffering for women, increase the number of successful treatments and cut costs for taxpayers. Our goal is for the test to be available by the start of 2026,” says Yvonne Lundberg Giwercman, who is also the CEO of the company that developed the oral swab test.

Empa researchers from the Cellulose and Wood Materials laboratory have now developed a bio-based material that cleverly avoids this compromise. Not only is it completely biodegradable, it is also tear-resistant and has versatile functional properties. All this with minimal processing steps and without chemicals — you can even eat it. Its secret: It’s alive.

Optimized by nature

As the basis for their novel material, the researchers used the mycelium of the split-gill mushroom, a widespread edible fungus that grows on dead wood. Mycelia are root-like filamentous fungal structures that are already being actively researched as potential sources of materials. Normally, the mycelial fibers — known as hyphae — are cleaned and, if necessary, chemically processed, which brings about the above-mentioned trade-off between performance and sustainability.

The Empa researchers chose a different approach. Instead of treating the mycelium, they use it as a whole. As it grows, the fungus not only forms hyphae, but also a so-called extracellular matrix: a network of various fiber-like macromolecules, proteins and other biological substances that the living cells secrete. “The fungus uses this extracellular matrix to give itself structure and other functional properties. Why shouldn’t we do the same?” explains Empa researcher Ashutosh Sinha. “Nature has already developed an optimized system,” adds Gustav Nyström, head of the Cellulose and Wood Materials lab.

With a bit of additional optimization, the researchers gave nature a helping hand. From the enormous genetic diversity of the split-gill, they selected a strain that produces particularly high levels of two specific macromolecules: the long-chain polysaccharide schizophyllan and the soap-like protein hydrophobin. Due to their structure, hydrophobins collect at interfaces between polar and apolar liquids, for example water and oil. Schizophyllan is a nanofiber: less than a nanometer thick, but more than a thousand times as long. Together, these two biomolecules give the living mycelium material properties that make it suitable for a wide range of applications.

A living emulsifier

The researchers demonstrated the versatility of their material in the laboratory. In their study, which was published recently in the journal Advanced Materials, they showcased two possible applications for the living material: a plastic-like film and an emulsion. Emulsions are mixtures of two or more liquids that normally do not mix. All you have to do to see an example is open the fridge: Milk, salad dressing or mayonnaise are all emulsions. And various cosmetics, paints and varnishes also take the form of emulsions.

One challenge is to stabilize such mixtures so that they do not separate into the individual liquids over time. This is where the living mycelium shows its strengths: Both the schizophyllan fibers and the hydrophobins act as emulsifiers. And the fungus keeps releasing more of these molecules. “This is probably the only type of emulsion that becomes more stable over time,” says Sinha. Both the fungal filaments themselves and their extracellular molecules are completely non-toxic, biologically compatible and edible — the split-gill mushroom is routinely eaten in many parts of the world. “Its use as an emulsifier in the cosmetics and food industry is therefore particularly interesting,” says Nyström.

From compost bags to batteries

The living fungal network is also suitable for classic material applications. In a second experiment, the researchers manufactured the mycelium into thin films. The extracellular matrix with its long schizophyllan fibers gives the material very good tensile strength, which can be further enhanced by targeted alignment of the fungal and polysaccharide fibers within it.

“We combine the proven methods for processing fiber-based materials with the emerging field of living materials,” explains Nyström. Sinha adds: “Our mycelium is a living fiber composite, so to speak.” The researchers can control the fungal material’s properties by changing the conditions under which the fungus grows. It would also be conceivable to use other fungal strains or species that produce other functional macromolecules.

Working with the living material also presents certain challenges. “Biodegradable materials always react to their environment,” says Nyström. “We want to find applications where this interaction is not a hindrance but maybe even an advantage.” However, its biodegradability is only part of the story for the mycelium. It is also a biodegrader: The split-gill mushrooms can actively decompose wood and other plant materials. Sinha sees another potential application here: “Instead of compostable plastic bags, it could be used to make bags that compost the organic waste themselves,” says the researcher.

There are also promising applications for the mycelium in the field of sustainable electronics. For example, the fungal material shows a reversible reaction to moisture and could be used to produce biodegradable moisture sensors. Another application that Nyström’s team is currently working on combines the living material with two other research projects from the Cellulose and Wood Materials laboratory: the fungal biobattery and the paper battery. “We want to produce a compact, biodegradable battery whose electrodes consist of a living ‘fungal paper’,” says Sinha.

Plants have small pores on the underside of their leaves, known as stomata. When the sun rises, these pores open and the plants absorb carbon dioxide (CO₂) from the atmosphere, which they need, in addition to sunlight and water, for photosynthesis. At the same time, water evaporates through the open stomata; for a tree, this may be several hundred liters per day.

When water is scarce, plants can close their stomata and thus prevent it from evaporating too much water. The fact that plants have this protective mechanism at their disposal is nothing new. Until now, however, it has not been clear when this closure occurs and what the trigger was.Researchers at the Department of Environmental Sciences at the University of Basel have provided new findings in the scientific journal Nature Plants. Most of the measurement data comes from the University of Basel’s forest laboratory in Hölstein, in the canton of Basel-Landschaft, where a crane makes it possible to study processes in the crowns of mature trees.

A balancing act within the canopy

The evaporation of water through the stomata is a passive process during CO₂ absorption. Water loss is therefore the price a plant pays for photosynthesis. By closing the stomata, it can stop evaporation, but then it cannot photosynthesize.

“When it comes to plants, researchers have traditionally focused on photosynthesis. So it was previously assumed that trees treated this process as a priority and therefore kept the stomata open for as long as possible to absorb CO₂, only closing them when there was no other option,” explains study leader Professor Ansgar Kahmen.

When water evaporates through the stomata, negative pressure is created within the cells and the xylem (i.e. the woody tissue that transports water up from the roots). This suction pulls water up from the roots, via the xylem, into the growth layer of the trunk and into the tree crown. There it replaces the water that has been released into the atmosphere.

Preventing the system from collapsing

It usually takes trees all night to replace the water lost during the day. During this time, the stomata are closed and the plant cells fill up with water. This creates the turgor pressure on the cell walls that is necessary for the elongation growth of the cells. Trees therefore grow at night.

If the soil is dry, there is no water to fully replenish their water reserves. As a result, the water saturation in the cells is too low and the turgor pressure remains low. This inhibits tree growth even in intermediately dry conditions. With increasing levels of drought, the suction in the cells and vascular pathways becomes stronger and stronger until at some point the water columns in the woody tissue break. This results in air bubbles, known as embolisms. “When this happens, irreparable damage occurs, the water transport system collapses and the plant eventually dies,” says Ansgar Kahmen.

Water supply in the tree is key

It used to be assumed that, in order to maintain photosynthesis for as long as possible, trees would close their stomata only shortly before the onset of these embolisms. The new study now shows that the stomata remain closed at an earlier point in time, namely when water absorption at night has become difficult. “For the first time, we were able to show that a tree does not even open its stomata in the morning if it cannot absorb enough water overnight,” says Kahmen. This means that the tree forgoes photosynthesis in favor of growth.

According to Kahmen, this prioritization makes sense: If the plant stops growing due to a shortage of water, then, no matter how much photosynthesis it carries out, it will not be able to use the resulting products. “So the aim is not to optimize photosynthesis and maintain it for as long as possible, but to use the products of photosynthesis as efficiently as possible for growth,” says the plant physiologist.

Carbon cycle and climate models

The findings could also influence calculations relating to carbon sequestration by forests. When the stomata are open for shorter periods during drought than previously expected, the trees absorb less carbon dioxide from the atmosphere. “Climate models that assume a certain growth in carbon storage volume would therefore have to be adapted,” says lead author Richard L. Peters, a former postdoc at the University of Basel and now professor at the Technical University of Munich. Particularly in the context of climate change, which is leading to warmer and, above all, drier summers in countries including Switzerland, carbon uptake could change more dramatically than previously assumed.

“What is remarkable is that our early stomatal closure observations apply to all tree species, whether deciduous or coniferous. How well a tree species copes with drought therefore cannot be solely determined by the process of stomata closure” says Peters.

The research, published in The Astrophysical Journal Letters, could one day help to unlock some of the universe’s deepest mysteries, including how gravity works at its most fundamental level.

“There is a lot we can learn from getting these precise measurements of gravitational waves,” said Darling, professor in the Department of Astrophysical and Planetary Sciences. “Different flavors of gravity could lead to lots of different kinds of gravitational waves.”

To understand how such waves work, it helps to picture Earth as a small buoy bobbing in a stormy ocean.

Darling explained that, throughout the history of the universe, countless supermassive black holes have engaged in a volatile dance: These behemoths spiral around each other faster and faster until they crash together. Scientists suspect that the resulting collisions are so powerful they, literally, generate ripples that spread out into the universe.

This background noise washes over our planet all the time, although you’d never know it. The kinds of gravitational waves that Darling seeks to measure tend to be very slow, passing our planet over the course of years to decades.

In 2023, a team of scientists belonging to the NANOGrav collaboration achieved a coup by measuring that cosmic wave pool. The group recorded how the universe’s gravitational wave background stretched and squeezed spacetime, affecting the light coming to Earth from celestial objects known as pulsars, which act somewhat like cosmic clocks.

But those detailed measurements only captured how gravitational waves move in a single direction — akin to waves flowing directly toward and away from a shoreline. Darling, in contrast, wants to see how gravitational waves also move from side-to-side and up and down compared to Earth.

In his latest study, the astrophysicist got help from another class of celestial objects: quasars, or unusually bright, supermassive black holes sitting at the centers of galaxies. Darling searches for signals from gravitational waves by precisely measuring how quasars move compared to each other in the sky. He hasn’t spotted those signals yet, but that could change as more data become available.

“Gravitational waves operate in three dimensions,” Darling said. “They stretch and squeeze spacetime along our line of sight, but they also cause objects to appear to move back and forth in the sky.”

Galaxies in motion

The research drills down on the notoriously tricky task of studying how celestial objects move, a field known as astrometry.

Darling explained that quasars rest millions of light-years or more from Earth. As the glow from these objects speeds toward Earth, it doesn’t necessarily proceed in a straight line. Instead, passing gravitational waves will deflect that light, almost like a baseball pitcher throwing a curve ball.

Those quasars aren’t actually moving in space, but from Earth, they might look like they are — a sort of cosmic wiggling happening all around us.

“If you lived for millions of years, and you could actually observe these incredibly tiny motions, you’d see these quasars wiggling back and forth,” Darling said.

Or that’s the theory. In practice, scientists have struggled to observe those wiggles. In part, that’s because these motions are hard to observe, requiring a precision 10 times greater than it would take to watch a human fingernail growing on the moon from Earth. But our planet is also moving through space. Our planet orbits the sun at a speed of roughly 67,000 miles per hour, and the sun itself is hurtling through space at a blistering 850,000 miles per hour.

Detecting the signal from gravitational waves, in other words, requires disentangling Earth’s own motion from the apparent motion of quasars. To begin that process, Darling drew on data from the European Space Agency’s Gaia satellite. Since Gaia’s launch in 2013, its science team has released observations of more than a million quasars over about three years.

Darling took those observations, split the quasars into pairs, then carefully measured how those pairs moved relative to each other.

His findings aren’t detailed enough yet to prove that gravitational waves are making quasars wiggle. But, Darling said, it’s an important search — unraveling the physics of gravitational waves, for example, could help scientists understand how galaxies evolve in our universe and help them test fundamental assumptions about gravity.

The astrophysicist could get some help in that pursuit soon. In 2026, the Gaia team plans to release five-and-a-half more years of quasar observations, providing a new trove of data that might just reveal the secrets of the universe’s gravitational wave background.

“If we can see millions of quasars, then maybe we can find these signals buried in that very large dataset,” he said.

But where there is water, there are waterbirds. Little is known about the impacts — positive or negative — floating solar projects may have on birds and other wildlife. A paper from the University of California, Davis, published in the journal Nature Water, is among the first to outline key considerations to better align renewable energy and biodiversity goals.

Birds face many threats — from habitat loss and climate change to pollution and avian influenza — and many populations are in decline.

“That’s why it’s so important to understand how waterbirds are going to respond to floating solar and if there is the possibility for conservation concessions at new floating solar facilities,” said corresponding author Elliott Steele, a postdoctoral scholar with the UC Davis Wild Energy Center within the Energy and Efficiency Institute. “We want to advance clean energy while promoting healthy, functional environments. Achieving this balance requires that we rigorously study and understand how wildlife responds to floating solar so we can ensure that negative impacts are avoided and potential ecological benefits are realized.”

Five considerations

Drawing from their scientific field observations of birds interacting with floating PV systems, the authors examined various ways such systems could impact birds, and vice versa. They concluded that future research on FPV-waterbirds interactions should examine:

• How waterbirds interact with each part of the floating PV infrastructure.
• The direct and indirect effects waterbirds and floating solar projects may have on each other.
• How bird conservation strategies may vary by site, region or season.
• How to best monitor waterbirds at floating solar sites.
• The potential for pollutants to be released or leached from floating solar infrastructure and what can be done to mitigate risks.

“Our team has been documenting such a diversity of bird behavior with floating PV, so we immediately knew this was a very important interaction, especially given the precipitous decline in waterbird numbers globally,” said senior author and UC Davis Professor Rebecca R. Hernandez, director of the UC Davis Wild Energy Center. “Humans are also responding to waterbirds on floating PV, sometimes with deterrence. We leveraged our team’s expertise in ecology and energy system science to identify risks and solution pathways such that waterbirds and floating PV can coexist.”

Critical threshold of development

The Wild Energy Center is conducting research to begin to answer some of those questions. During their field work, the authors have seen black-crowned night herons resting on a floating solar structure before dawn, double-breasted cormorants jockeying for a favorable site, black phoebes nesting under panels, and more.

They note that while many types of wildlife use artificial water bodies, the authors focused on waterbirds because they interact above and below floating solar panels and are easy to observe.

So far, the scientists have observed mostly positive waterbird interactions with floating solar and additional benefits for people. For example, a farm that installs floating solar over an irrigation pond can save water by reducing evaporation, as well as produce clean energy without taking up cropland. Yet more research is required to fully understand the risks and benefits of introducing a large, relatively new technology into an aquatic environment.

“There are some things we wished we’d known before other kinds of renewable energy were developed,” said coauthor Emma Forester, a Ph.D. candidate with the UC Davis Land, Air and Water Resources department and the Wild Energy Center. “While we’re at this critical threshold of renewable energy development, we want to put more thought into the design that can benefit birds and other wildlife as we go forward.”

Additional coauthors include Alexander Cagle and Jocelyn Rodriguez of UC Davis, Tara Conkling and Todd Katzner of U.S. Geological Survey, Sandor Kelly of University of Central Florida, Giles Exley and Alona Armstrong of Lancaster University, and Giulia Pasquale and Miriam Lucia Vincenza Di Blasi of Innovation of Enel Green Power in Italy.

The study was funded by the UC Office of the President’s California Climate Action Seed Grant, Enel Green Power, U.S. Department of Energy, U.S. Bureau of Land Management and U.S. Geological Survey.

The team at WEHI in Melbourne, Australia, have identified a small molecule that can selectively block cell death.

Published in Science Advances, the findings lay the groundwork for next-generation neuroprotective drugs for degenerative conditions, which currently have no cure or treatments to stop their progression.

At a glance

• Researchers have discovered how to block cell death, an important first step towards slowing neurodegenerative conditions.

• The study from team at WEHI, including researchers from the Parkinson’s Disease Research Centre, has revealed new insight into the mechanisms behind cell death and how it is controlled.

• The discovery was made possible through the advanced screening technologies of the National Drug Discovery Centre.

A new hope in the fight against degenerative conditions

Millions of cells are programmed to die in our bodies every day. But excessive cell death can cause degenerative conditions including Parkinson’s disease and Alzheimer’s disease, with the premature death of brain cells a cause of symptoms in these diseases.

Professor Grant Dewson, co-corresponding author and head of the WEHI Parkinson’s Disease Research Centre, said: “Currently there are no treatments that prevent neurons from dying to slow the progression of Parkinson’s. Any drugs that could be able to do this could be game changing.”

The new study aimed to find new chemicals that block cell death and could be useful to treat degenerative diseases in the future.

To identify novel small molecules, the team worked with researchers in the National Drug Discovery Centre, headquartered at WEHI.

A high-throughput screen of over 100,000 chemical compounds identified one that was effective at stopping cells from dying, by interfering with a well-understood cell death protein.

Co-corresponding author Professor Guillaume Lessene said: “We were thrilled to find a small molecule that targets a killer protein called BAX and stops it working.

“While not the case in most cells, in neurons turning off BAX alone may be sufficient to limit cell death.”

Building on decades of pioneering cell death research

The new research builds on decades of world-leading WEHI discoveries in cell death. A pioneering discovery at WEHI in 1988 of a protein that stopped programmed cell death sparked huge interest in the field, and has since led to a new drug to treat cancer.

While drugs that trigger cell death are transforming treatment of certain cancers, the development of cell death blockers — that could be similarly game-changing for neurodegenerative conditions — has proven challenging.

The new molecule targets a killer protein called BAX which kills cells by damaging mitochondria, the powerhouse of cells.

Lead author and Dewson Lab researcher Kaiming Li said: “For the first time we could keep BAX away from mitochondria and keep cells alive using this molecule.

“This could pave the way for next-generation cell death inhibitors to combat degenerative conditions.”

The study demonstrates the potential to identify drugs that block cell death and may open a new avenue to find much-needed disease-modifying drugs for neurodegenerative conditions such as Parkinson’s and Alzheimer’s.

The WEHI Parkinson’s Disease Research Centre is focusing on its expertise in cell death, ubiquitin signalling, mitochondria and inflammation in the hunt for disease-modifying therapies for Parkinson’s.

By using a multidisciplinary approach to build understanding of the mechanisms behind the disease, the centre hopes to accelerate the discovery of drugs to stop disease progression, transforming the lives of those living with the condition.

The new research was supported by the Bodhi Education Fund and the National Health and Medical Research Council.